Consolidated Statements of Cash Flows - USD ($) $ in Thousands		3 Months Ended
		Mar. 31, 2020		Mar. 31, 2019
Cash flows from operating activities:
Net loss		$ (200,086)		$ (15,262)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:
Depreciation and amortization expense		7,858		10,190
Loss (income) from equity method investments		39,643		(955)
Amortization of debt costs		16,814		7,988
Stock-based compensation		1,372		1,334
Long-lived asset impairments and other store closing costs		157,515		0
Loss on forward contracts for the issuance of convertible preferred stock		0		16,787
Loss on net asset exchange for the formation of the joint ventures		1,655		19,514
Interest expense recognized on interest rate swap		10,810		0
Deferred income tax benefit		(47,677)		(5,064)
Other		(2,107)		(21)
Changes in assets and liabilities:
Decrease (increase) in receivables		17,824		(12,567)
Decrease (increase) in inventory		17,578		(6,886)
Increase in prepaid and other current assets		(8,401)		(3,658)
Increase in accounts payable		3,346		57,722
Decrease in deferred revenue and accrued liabilities		(22,686)		4,437
Decrease in net lease liabilities		(7,035)		(8,485)
Other operating activities		1,492		3,637
Net cash (used in) provided by operating activities		(12,085)		68,711
Cash flows from investing activities:
Capital expenditures		(3,858)		(3,017)
Refranchising proceeds, net of store acquisition costs		180		667
Proceeds from net asset exchange		18,211		101,000
Capital contribution to the newly formed joint ventures		0		(13,079)
Net cash provided by investing activities		14,533		85,571
Cash flows from financing activities:
Borrowings under revolving credit facility		30,000		22,000
Payments on revolving credit facility		0		(22,000)
Proceeds from the issuance of convertible preferred stock		0		199,950
Original issuance discount and revolving credit facility fees		0		(10,365)
Fees associated with the issuance of convertible preferred stock		0		(12,564)
Minimum tax withholding requirements		(54)		(120)
Net cash provided by (used) in financing activities		18,227		(84,411)
Effect of exchange rate changes on cash and cash equivalents		(277)		22
Net increase in cash and cash equivalents		20,398		69,893
Beginning balance, cash and cash equivalents		117,046		67,224
Ending balance, cash and cash equivalents		137,444		137,117
Non-cash investing activities:
Net assets contributed to the joint ventures (Note 8)	[1]	0	[2]	202,487
Tranche B-1
Cash flows from financing activities:
Payments on term loan facility		0		(147,312)
Tranche B-2
Cash flows from financing activities:
Payments on term loan facility		$ (11,719)		$ (114,000)

[1] Capital expenditures included in current liabilities were not material during the three months ended March, 31, 2020 and March 31, 2019, respectively.

[2] Net of tax expense of $0.4 million and $0.1 million, respectively, for the three months ended March 31, 2020 and 2019.